152 related articles for article (PubMed ID: 32054689)
1. Investigating the genetic susceptibility to exertional heat illness.
Gardner L; Miller DM; Daly C; Gupta PK; House C; Roiz de Sa D; Shaw MA; Hopkins PM
J Med Genet; 2020 Aug; 57(8):531-541. PubMed ID: 32054689
[TBL] [Abstract][Full Text] [Related]
2. Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness.
Fiszer D; Shaw MA; Fisher NA; Carr IM; Gupta PK; Watkins EJ; Roiz de Sa D; Kim JH; Hopkins PM
Anesthesiology; 2015 May; 122(5):1033-46. PubMed ID: 25658027
[TBL] [Abstract][Full Text] [Related]
3. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.
Kraeva N; Sapa A; Dowling JJ; Riazi S
Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467
[TBL] [Abstract][Full Text] [Related]
4. Is there a link between malignant hyperthermia and exertional heat illness?
Muldoon S; Deuster P; Brandom B; Bunger R
Exerc Sport Sci Rev; 2004 Oct; 32(4):174-9. PubMed ID: 15604937
[TBL] [Abstract][Full Text] [Related]
5. Exertional Heat Stroke and Susceptibility to Malignant Hyperthermia in an Athlete: Evidence for a Link?
Poussel M; Guerci P; Kaminsky P; Heymonet M; Roux-Buisson N; Faure J; Fronzaroli E; Chenuel B
J Athl Train; 2015 Nov; 50(11):1212-4. PubMed ID: 26565425
[TBL] [Abstract][Full Text] [Related]
6. The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility.
Sambuughin N; Capacchione J; Blokhin A; Bayarsaikhan M; Bina S; Muldoon S
Clin Genet; 2009 Dec; 76(6):564-8. PubMed ID: 19807743
[TBL] [Abstract][Full Text] [Related]
7. RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor Dysfunction.
Kruijt N; den Bersselaar LV; Snoeck M; Kramers K; Riazi S; Bongers C; Treves S; Jungbluth H; Voermans N
Curr Pharm Des; 2022; 28(1):2-14. PubMed ID: 34348614
[TBL] [Abstract][Full Text] [Related]
8. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis.
Dlamini N; Voermans NC; Lillis S; Stewart K; Kamsteeg EJ; Drost G; Quinlivan R; Snoeck M; Norwood F; Radunovic A; Straub V; Roberts M; Vrancken AF; van der Pol WL; de Coo RI; Manzur AY; Yau S; Abbs S; King A; Lammens M; Hopkins PM; Mohammed S; Treves S; Muntoni F; Wraige E; Davis MR; van Engelen B; Jungbluth H
Neuromuscul Disord; 2013 Jul; 23(7):540-8. PubMed ID: 23628358
[TBL] [Abstract][Full Text] [Related]
9. Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance.
Hoppe K; Jurkat-Rott K; Kranepuhl S; Wearing S; Heiderich S; Merlak S; Klingler W
Sci Rep; 2021 Feb; 11(1):3445. PubMed ID: 33564012
[TBL] [Abstract][Full Text] [Related]
10. Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations.
Carsana A
ScientificWorldJournal; 2013; 2013():531465. PubMed ID: 23476141
[TBL] [Abstract][Full Text] [Related]
11. The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations.
Knuiman GJ; Küsters B; Eshuis L; Snoeck M; Lammens M; Heytens L; De Ridder W; Baets J; Scalco RS; Quinlivan R; Holton J; Bodi I; Wraige E; Radunovic A; von Landenberg C; Reimann J; Kamsteeg EJ; Sewry C; Jungbluth H; Voermans NC
J Neurol; 2019 Apr; 266(4):876-887. PubMed ID: 30788618
[TBL] [Abstract][Full Text] [Related]
12. RYR1-related rhabdomyolysis: A common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction.
Voermans NC; Snoeck M; Jungbluth H
Rev Neurol (Paris); 2016 Oct; 172(10):546-558. PubMed ID: 27663056
[TBL] [Abstract][Full Text] [Related]
13. Collapse from exertional heat illness: implications and subsequent decisions.
Porter AM
Mil Med; 2003 Jan; 168(1):76-81. PubMed ID: 12546251
[TBL] [Abstract][Full Text] [Related]
14. Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of
Sadhasivam S; Brandom BW; Henker RA; McAuliffe JJ
Pharmacogenomics; 2019 Sep; 20(14):989-1003. PubMed ID: 31559918
[No Abstract] [Full Text] [Related]
15. Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility.
Endo Y; Groom L; Celik A; Kraeva N; Lee CS; Jung SY; Gardner L; Shaw MA; Hamilton SL; Hopkins PM; Dirksen RT; Riazi S; Dowling JJ
Nat Commun; 2022 Jun; 13(1):3403. PubMed ID: 35697689
[TBL] [Abstract][Full Text] [Related]
16. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
Muniz VP; Silva HC; Tsanaclis AM; Vainzof M
J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families.
Gillies RL; Bjorksten AR; Du Sart D; Hockey BM
Anaesth Intensive Care; 2015 Mar; 43(2):157-66. PubMed ID: 25735680
[TBL] [Abstract][Full Text] [Related]
18. Malignant Hyperthermia, Exertional Heat Illness, and RYR1 Variants: The Muscle May Not Be the Brain.
Sagui E
Anesthesiology; 2016 Feb; 124(2):510. PubMed ID: 26785433
[No Abstract] [Full Text] [Related]
19. Genetic epidemiology of malignant hyperthermia in the UK.
Miller DM; Daly C; Aboelsaod EM; Gardner L; Hobson SJ; Riasat K; Shepherd S; Robinson RL; Bilmen JG; Gupta PK; Shaw MA; Hopkins PM
Br J Anaesth; 2018 Oct; 121(4):944-952. PubMed ID: 30236257
[TBL] [Abstract][Full Text] [Related]
20. Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia.
Michelucci A; Paolini C; Boncompagni S; Canato M; Reggiani C; Protasi F
FASEB J; 2017 Aug; 31(8):3649-3662. PubMed ID: 28465322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]